PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-European stocks slip after four-day run, U.S. tariffs hit Airbus

Thu, 13th Aug 2020 09:39

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* FTSE 100 leads declines on ex-dividend trading

* Investors confident of imminent U.S. stimulus - analysts

* Thyssenkrupp slides on flagging losses in steel unit

* Danish brewer Carlsberg falls on sales warning in key
markets
(Adds comments; updates prices)

By Sruthi Shankar and Sagarika Jaisinghani

Aug 13 (Reuters) - European stocks fell on Thursday as
simmering tensions between the United States and China, and
elusive U.S. fiscal stimulus, pushed investors to book profits
after four straight sessions of gains, while Airbus dipped as
Washington left aircraft tariffs unchanged.

The pan-European STOXX 600 was off 0.4%, with
Airbus sliding 1.2% after the U.S. government said it
would maintain 15% tariffs on planes and 25% tariffs on other
European goods, despite moves to resolve a long-standing dispute
over aircraft subsidies.

London's FTSE 100 was at the front of declines among
major European bourses, led by AstraZeneca, BP,
Diageo, Glaxosmithkline and Legal&General
, which traded without entitlement to a dividend payout.

Still, with the U.S. S&P 500 index within striking
distance of a record high, analysts said there were few cues for
global equities to pull back, with investors also disregarding
U.S-China angst.

"There's no stopping this market at the moment," said
Michael Baker, an analyst at ETX Capital.

"There's not a lot negative sentiment (and) the market is
fairly confident that a U.S. stimulus deal will be reached even
if it's a last minute one."

U.S. Democrats and Republicans remain deadlocked after weeks
of wrangling over a fifth coronavirus aid bill. President Donald
Trump on Wednesday accused congressional Democrats of not
wanting to negotiate because he was refusing to go along with
"ridiculous" spending requests unrelated to the pandemic.

In Europe, the STOXX 600 is still about 14% below its
all-time high as data points to a slower-than-expected rebound
from the pandemic. A survey on Thursday showed German companies
expect business to return to normal in an average of 11 months,
with the number even higher for firms in the services sector.

Struggling conglomerate Thyssenkrupp plunged 13.1%
after it said its steel unit would rack up 1 billion euros ($1.2
billion) in operating losses this year, raising pressure to fix
or sell the division. The stock is on course for its biggest
one-day decline in three months.

Danish brewer Carlsberg slid 4.7% on warning that
lockdowns will impact sales in the second half of the year in
its key markets of China and Western Europe.

TUI, the world's largest tourism company, fell 3.0%
as it sunk to a 1.1 billion euro ($1.30 billion) loss in the
third quarter due to the COVID-19 pandemic.
(Reporting by Sruthi Shankar in Bengaluru; Additional reporting
by Sagarika Jaisinghani; Editing by Arun Koyyur, Bernard Orr)

More News
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.